Literature DB >> 1636249

Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.

M Werner1, H Maschek, V Kaloutsi, H Choritz, A Georgii.   

Abstract

Chromosome analyses of bone marrow and peripheral blood cells were performed in a total of 51 patients with myelodysplastic syndromes (MDS) simultaneously with histopathological examination of resin-embedded bone marrow biopsies. Diagnosis of MDS was established by histopathology according to the French-American-British (FAB) classification, and reassessed by haematological data and clinical course. Clonal karyotypic changes were found in 30 of the 51 patients (59%): in 15 of 19 (79%) patients with refractory anaemia, 7 of 11 (64%) with refractory anaemia and excess of blasts (RAEB), 6 of 10 (60%) with RAEB in transformation, and 2 of 11 (18%) with chronic myelomonocytic leukaemia. The following three features of the histopathology revealed positive correlations with karyotype abnormalities: all cases of myelofibrosis in MDS (7/51) were accompanied by chromosome aberrations, microforms of megakaryocytes with reduced nuclear lobulation were observed in 18 of 30 cases with karyotype changes, and hypocellularity of haematopoiesis was associated with aberrations of chromosome 7 in 2 of 4 cases. No positive correlations were revealed between abnormal karyotypes and the transformation to acute leukaemia. The survival times were significantly decreased in patients with complex (3 and more) karyotype changes, when compared with patients with single (1-2) chromosome aberrations or normal karyotype, independently of the FAB classification.

Entities:  

Mesh:

Year:  1992        PMID: 1636249     DOI: 10.1007/bf01607138

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  30 in total

1.  Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.

Authors:  M Gyger; C Infante-Rivard; G D'Angelo; L Forest; P Lussier
Journal:  Am J Hematol       Date:  1988-05       Impact factor: 10.047

2.  Successful treatment of refractory anemia with high-dose methylprednisolone.

Authors:  T Motoji; M Teramura; M Takahashi; K Oshimi; M Okada; K Kusakabe; H Mizoguchi
Journal:  Am J Hematol       Date:  1990-01       Impact factor: 10.047

3.  Myelofibrosis in primary myelodysplastic syndromes.

Authors:  E Del Potro; R Martinez; I Krsnik; M Lopez Rubio; A Gonzalez Fernandez; A Villegas
Journal:  Br J Haematol       Date:  1989-10       Impact factor: 6.998

4.  Bone marrow karyotype and prognosis in primary myelodysplastic syndromes.

Authors:  R Billström; T Thiede; S Hansen; S Heim; U Kristoffersson; N Mandahl; F Mitelman
Journal:  Eur J Haematol       Date:  1988-10       Impact factor: 2.997

5.  Myelodysplastic syndrome with monosomy 7 in adulthood: a distinct preleukaemic disorder.

Authors:  L Dezza; M Cazzola; G Bergamaschi; V L Burgio; C C Stella; C Fenoglio; A Ghizzi; G Nalli; F Sacchi; E Ascari
Journal:  Haematologica       Date:  1983 Nov-Dec       Impact factor: 9.941

6.  Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis.

Authors:  K Ohyashiki; I Sasao; J H Ohyashiki; T Murakami; A Iwabuchi; T Tauchi; M Saito; S Nakazawa; H Serizawa; Y Ebihara
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

7.  Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS).

Authors:  H J Weh; A Calavrezos; D Seeger; R Kuse; D K Hossfeld
Journal:  Eur J Haematol       Date:  1987-02       Impact factor: 2.997

8.  The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations.

Authors:  G Tricot; M A Boogaerts; C De Wolf-Peeters; H Van den Berghe; R L Verwilghen
Journal:  Br J Haematol       Date:  1985-04       Impact factor: 6.998

9.  Hypoplastic myelodysplastic syndrome.

Authors:  S Nand; J E Godwin
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

10.  Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.

Authors:  A Ríos; M C Cañizo; M A Sanz; T Vallespí; G Sanz; M Torrabadella; F Gomis; C Ruiz; J F San Miguel
Journal:  Br J Haematol       Date:  1990-05       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.